Camila Braz Pereira da Costa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Camila Braz Pereira da Costa has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Francislene Juliana Martins
Federal Fluminense University
2 shared publications - Helena Carla Castro
Universidade Federal Fluminense, Hospital Universitário Antônio Pedro, Programa de Pós-graduação em Patologia, 24033-900 Niterói, RJ, Brazil; Universidade Federal Fluminense, Instituto de Biologia, Programa de Pós-graduação em Ciências e Biotecnologia, CEP 24210-130, Niterói, RJ, Brazil
2 shared publications - Norman Ratcliffe
Faculty of Applied Sciences, University of the West of England, Frenchay Campus, Coldharbour Lane, Bristol, BS16 1QY, Bristol, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND
2 shared publications - Rafael Cisne
Fluminense Federal University, Brazil
2 shared publications - Ana Claudia de Menezes Cruz
Universidade Federal Fluminense (UFF), Brazil
1 shared publication - Jorge Luiz Coelho Mattos
Instituto Vital Brazil, Niterói, Brazil
1 shared publication
Latest Publications
- 20 September 2022
- Published by Taylor & Francis in Toxin Reviews
- Vol. 42 (1) , 478-490
Production of hyperimmune sera: a study of digestion and fractionation methodologies for the purification process of heterologous immunoglobulins
Several scientific studies to evaluate the process of digestion and fractionation of immunoglobulins have been carried out in order to improve the production of hyperimmune sera. Today, quality, safety, and production efficiency, along with the development of optimized, robust, and cost-effective processes are priorities. Thus, this work analyzed previous studies of enzymatic digestion of heterologous immunoglobulin G, as well as studies of protein fractionation with caprylic acid, to verify the experimental conditions and their impacts on production processes. The establishment of possible variables; such as concentration, pH, time, and temperature; may allow optimization of the production of hyperimmune sera. Most of the digestive processes evaluated took place at 37° C, pH 3.2, with times longer than 90 minutes, and pepsin inactivation between pH 7.0 and 7.2, while fractionation with caprylic acid used a concentration of 5%, 37° C, and pH 5.0–5.8, for 60 minutes. This work aimed to establish, the ideal conditions to be applied in the production of hyperimmune sera.
- 20 September 2022
- Published by Taylor & Francis in Toxin Reviews
- Vol. 42 (1) , 478-490
Production of hyperimmune sera: a study of digestion and fractionation methodologies for the purification process of heterologous immunoglobulins
Several scientific studies to evaluate the process of digestion and fractionation of immunoglobulins have been carried out in order to improve the production of hyperimmune sera. Today, quality, safety, and production efficiency, along with the development of optimized, robust, and cost-effective processes are priorities. Thus, this work analyzed previous studies of enzymatic digestion of heterologous immunoglobulin G, as well as studies of protein fractionation with caprylic acid, to verify the experimental conditions and their impacts on production processes. The establishment of possible variables; such as concentration, pH, time, and temperature; may allow optimization of the production of hyperimmune sera. Most of the digestive processes evaluated took place at 37° C, pH 3.2, with times longer than 90 minutes, and pepsin inactivation between pH 7.0 and 7.2, while fractionation with caprylic acid used a concentration of 5%, 37° C, and pH 5.0–5.8, for 60 minutes. This work aimed to establish, the ideal conditions to be applied in the production of hyperimmune sera.
- 3 November 2021
- Published by Taylor & Francis in Expert Opinion on Drug Discovery
- Vol. 17 (2) , 121-137
Using in vivo animal models for studying SARS-CoV-2
The search for an animal model capable of reproducing the physiopathology of the COVID-19, and also suitable for evaluating the efficacy and safety of new drugs has become a challenge for many rese...
- 3 November 2021
- Published by Taylor & Francis in Expert Opinion on Drug Discovery
- Vol. 17 (2) , 121-137
Using in vivo animal models for studying SARS-CoV-2
The search for an animal model capable of reproducing the physiopathology of the COVID-19, and also suitable for evaluating the efficacy and safety of new drugs has become a challenge for many rese...